Stock ALLO ALLOGENE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Allogene Therapeutics, Inc.

Equities

ALLO

US0197701065

Real-time Estimate Cboe BZX
Other stock markets
 02:16:48 2024-06-10 pm EDT 		5-day change 1st Jan Change
2.385 USD +2.80% Intraday chart for Allogene Therapeutics, Inc. -3.98% -24.92%
May. 31 Piper Sandler Starts Allogene Therapeutics With Overweight Rating, $11 Price Target MT
May. 21 Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ALLO Stock
  4. Revisions Allogene Therapeutics, Inc.